Impact of Hyperhomocysteinemia and Different Dietary Interventions on Cognitive Performance in a Knock-in Mouse Model for Alzheimer’s Disease
暂无分享,去创建一个
M. Parnham | T. Saido | R. Gurke | G. Geisslinger | H. Nieraad | N. de Bruin | O. Arne | M. Hofmann | U. Till | Mike Schmidt | D. Schmidt | T. Saito
[1] J. Reichert,et al. Antibodies to watch in 2020 , 2019, mAbs.
[2] V. Calsolaro,et al. The Use of Antipsychotic Drugs for Treating Behavioral Symptoms in Alzheimer’s Disease , 2019, Front. Pharmacol..
[3] P. Skolnick,et al. Be positive about negatives–recommendations for the publication of negative (or null) results , 2019, European Neuropsychopharmacology.
[4] D. Balschun,et al. Neural oscillations during cognitive processes in an App knock-in mouse model of Alzheimer’s disease pathology , 2019, Scientific Reports.
[5] N. Ferreirós,et al. A validated LC-MS/MS method for the determination of homocysteic acid in biological samples. , 2019, Journal of pharmaceutical and biomedical analysis.
[6] T. Saido,et al. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer’s disease , 2019, BMC Neuroscience.
[7] R. J. McDonald,et al. Age-dependent behavioral and biochemical characterization of single APP knock-in mouse (APPNL-G-F/NL-G-F) model of Alzheimer's disease , 2019, Neurobiology of Aging.
[8] Piyoosh Sharma,et al. Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies , 2019, Progress in Neurobiology.
[9] G. Logroscino,et al. A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease , 2019, Nature Reviews Neurology.
[10] W. M. van der Flier,et al. Exploring effects of Souvenaid on cerebral glucose metabolism in Alzheimer's disease , 2019, Alzheimer's & dementia.
[11] H. Fillit,et al. Translating the biology of aging into novel therapeutics for Alzheimer disease , 2018, Neurology.
[12] J. Kotlinska,et al. Assessment of spatial learning and memory in the Barnes maze task in rodents—methodological consideration , 2018, Naunyn-Schmiedeberg's Archives of Pharmacology.
[13] T. Saido,et al. Cognitive and emotional alterations in App knock-in mouse models of Aβ amyloidosis , 2018, BMC Neuroscience.
[14] A. Beery,et al. Inclusion of females does not increase variability in rodent research studies , 2018, Current Opinion in Behavioral Sciences.
[15] G. Zhu,et al. Betaine in Inflammation: Mechanistic Aspects and Applications , 2018, Front. Immunol..
[16] M. Fenech,et al. Homocysteine and Dementia: An International Consensus Statement , 2018, Journal of Alzheimer's disease : JAD.
[17] T. Saido,et al. Reduction in open field activity in the absence of memory deficits in the App NL−G−F knock-in mouse model of Alzheimer’s disease , 2018, Behavioural Brain Research.
[18] Hui Zheng,et al. Practical considerations for choosing a mouse model of Alzheimer’s disease , 2017, Molecular Neurodegeneration.
[19] R. D'Hooge,et al. Subtle behavioral changes and increased prefrontal-hippocampal network synchronicity in APPNL−G−F mice before prominent plaque deposition , 2017, Behavioural Brain Research.
[20] H. Lipp,et al. Automated dissection of permanent effects of hippocampal or prefrontal lesions on performance at spatial, working memory and circadian timing tasks of C57BL/6 mice in IntelliCage , 2017, Behavioural Brain Research.
[21] B. Winblad,et al. APP mouse models for Alzheimer's disease preclinical studies , 2017, The EMBO journal.
[22] D. Michaelson,et al. Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimer’s disease: a rationale for multi-nutrient dementia prevention , 2017, Journal of Lipid Research.
[23] J. McCabe,et al. Behavior of Male and Female C57BL/6J Mice Is More Consistent with Repeated Trials in the Elevated Zero Maze than in the Elevated Plus Maze , 2017, Front. Behav. Neurosci..
[24] S. Itohara,et al. Cognitive deficits in single App knock-in mouse models , 2016, Neurobiology of Learning and Memory.
[25] A. Smith,et al. Homocysteine, B Vitamins, and Cognitive Impairment. , 2016, Annual review of nutrition.
[26] J. Hardy,et al. The amyloid hypothesis of Alzheimer's disease at 25 years , 2016, EMBO molecular medicine.
[27] Valerio Zerbi,et al. A Dietary Treatment Improves Cerebral Blood Flow and Brain Connectivity in Aging apoE4 Mice , 2016, Neural plasticity.
[28] D. Kennedy. B Vitamins and the Brain: Mechanisms, Dose and Efficacy—A Review , 2016, Nutrients.
[29] A. Smith,et al. Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment , 2016, Journal of Alzheimer's disease : JAD.
[30] A. Rutjes,et al. Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment. , 2015, The Cochrane database of systematic reviews.
[31] D. Clair,et al. Bridging the translational divide: identical cognitive touchscreen testing in mice and humans carrying mutations in a disease-relevant homologous gene , 2015, Scientific Reports.
[32] G. Dubey,et al. Age dependent levels of plasma homocysteine and cognitive performance , 2015, Behavioural Brain Research.
[33] R. Collins,et al. Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals , 2014, The American journal of clinical nutrition.
[34] S. Itohara,et al. Single App knock-in mouse models of Alzheimer's disease , 2014, Nature Neuroscience.
[35] P. Vemuri,et al. Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences , 2014, Clinical epidemiology.
[36] Stephen A. Rappaport,et al. The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer’s disease , 2013, Alzheimer's Research & Therapy.
[37] L. Joosten,et al. Effects of Specific Multi-Nutrient Enriched Diets on Cerebral Metabolism, Cognition and Neuropathology in AβPPswe-PS1dE9 Mice , 2013, PloS one.
[38] Thomas E. Nichols,et al. Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment , 2013, Proceedings of the National Academy of Sciences.
[39] Charles D. Smith,et al. Induction of Hyperhomocysteinemia Models Vascular Dementia by Induction of Cerebral Microhemorrhages and Neuroinflammation , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[40] Nick C Fox,et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. , 2012, The New England journal of medicine.
[41] J. Roder,et al. Assessment of Social Interaction Behaviors , 2011, Journal of visualized experiments : JoVE.
[42] S. Chakrabarti,et al. Aging and antioxidants modulate rat brain levels of homocysteine and dehydroepiandrosterone sulphate (DHEA-S): Implications in the pathogenesis of Alzheimer's disease , 2010, Neuroscience Letters.
[43] K Safi,et al. Consistent behavioral phenotype differences between inbred mouse strains in the IntelliCage , 2010, Genes, brain, and behavior.
[44] Abderrahim Oulhaj,et al. Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial , 2010, PloS one.
[45] K. Zahs,et al. ‘Too much good news’ – are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease? , 2010, Trends in Neurosciences.
[46] D. Wald,et al. Effect of folic acid, with or without other B vitamins, on cognitive decline: meta-analysis of randomized trials. , 2010, The American journal of medicine.
[47] F. LaFerla,et al. Treatment of Alzheimer's Disease with Anti-Homocysteic Acid Antibody in 3xTg-AD Male Mice , 2010, PloS one.
[48] V. Bolivar. Intrasession and intersession habituation in mice: From inbred strain variability to linkage analysis , 2009, Neurobiology of Learning and Memory.
[49] L. Saksida,et al. A novel touchscreen-automated paired-associate learning (PAL) task sensitive to pharmacological manipulation of the hippocampus: a translational rodent model of cognitive impairments in neurodegenerative disease , 2009, Psychopharmacology.
[50] Q. Tian,et al. Hyperhomocysteinemia increases beta-amyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain. , 2009, The American journal of pathology.
[51] Jeffrey A. James,et al. Frequent amyloid deposition without significant cognitive impairment among the elderly. , 2008, Archives of neurology.
[52] B. Shukitt-Hale,et al. B-vitamin deficiency causes hyperhomocysteinemia and vascular cognitive impairment in mice , 2008, Proceedings of the National Academy of Sciences.
[53] F. D’Anselmi,et al. B-vitamin deprivation induces hyperhomocysteinemia and brain S-adenosylhomocysteine, depletes brain S-adenosylmethionine, and enhances PS1 and BACE expression and amyloid-β deposition in mice , 2008, Molecular and Cellular Neuroscience.
[54] R. Leighty,et al. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer’s transgenic mice , 2007, Neuroscience.
[55] A. Drzezga,et al. Gender differences in brain reserve , 2007, Journal of Neurology.
[56] M. P. McDonald,et al. Impaired spatial memory in APP-overexpressing mice on a homocysteinemia-inducing diet , 2007, Neurobiology of Aging.
[57] G. Weaving,et al. Behavioural and Psychological Symptoms of Alzheimer Type Dementia Are Not Correlated with Plasma Homocysteine Concentration , 2006, Dementia and Geriatric Cognitive Disorders.
[58] A. Tomarken,et al. Spatial and nonspatial escape strategies in the Barnes maze. , 2006, Learning & memory.
[59] A. Boldyrev,et al. Effect of homocysteine and homocysteic acid on glutamate receptors on rat lymphocytes , 2006, Bulletin of Experimental Biology and Medicine.
[60] J. Mann,et al. A controlled trial of homocysteine lowering and cognitive performance. , 2006, The New England journal of medicine.
[61] R. Obeid,et al. Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia , 2006, FEBS letters.
[62] Knut Engedal,et al. Plasma total homocysteine and memory in the elderly: The Hordaland Homocysteine study , 2005, Annals of neurology.
[63] Y. Terayama,et al. Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease. , 2005, Life sciences.
[64] J. Nadeau,et al. Homocysteine levels in A/J and C57BL/6J mice: genetic, diet, gender, and parental effects. , 2005, Physiological genomics.
[65] J. Piven,et al. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic‐like behavior in mice , 2004, Genes, brain, and behavior.
[66] G. Schwall,et al. Molecular analysis of homocysteic acid-induced neuronal stress. , 2004, Journal of proteome research.
[67] M. Siebler,et al. Implications for hyperhomocysteinemia: not homocysteine but its oxidized forms strongly inhibit neuronal network activity , 2004, Journal of the Neurological Sciences.
[68] M. S. Morris. Homocysteine and Alzheimer's disease , 2003, The Lancet Neurology.
[69] M. Mattson,et al. Folic Acid Deficiency and Homocysteine Impair DNA Repair in Hippocampal Neurons and Sensitize Them to Amyloid Toxicity in Experimental Models of Alzheimer's Disease , 2002, The Journal of Neuroscience.
[70] Sudha Seshadri,et al. Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease , 2002 .
[71] George Paxinos,et al. The Mouse Brain in Stereotaxic Coordinates , 2001 .
[72] R. Diaz-Arrastia,et al. Homocysteine and neurologic disease. , 2000, Archives of neurology.
[73] W. Kukull,et al. Anxiety of Alzheimer's disease: prevalence, and comorbidity. , 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.
[74] R Clarke,et al. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. , 1998, Archives of neurology.
[75] H. Brodaty,et al. ALZHEIMER'S DISEASE INTERNATIONAL , 1997, International journal of geriatric psychiatry.
[76] Santhosh K. P. Kumar,et al. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[77] D. Choi,et al. l-Homocysteate is a potent neurotoxin on cultured cortical neurons , 1987, Brain Research.
[78] C. Masters,et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[79] J. Homberg,et al. Impact of dietary n-3 polyunsaturated fatty acids on cognition, motor skills and hippocampal neurogenesis in developing C57BL/6J mice. , 2015, The Journal of nutritional biochemistry.
[80] S. Itohara,et al. Single APP knockin mouse models of Alzheimer’s disease , 2014 .
[81] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[82] Jia-min Zhuo,et al. Severe In vivo hyper-homocysteinemia is not associatedwith elevation of amyloid-beta peptides in the Tg2576 mice. , 2010, Journal of Alzheimer's disease : JAD.
[83] A. Smith,et al. Facts and recommendations about total homocysteine determinations: an expert opinion. , 2004, Clinical chemistry.
[84] S. Vollset,et al. The Hordaland Homocysteine Studies , 2001, Lipids.